Literature DB >> 25973058

Structural changes in the progression of atrial fibrillation: potential role of glycogen and fibrosis as perpetuating factors.

Ling Zhang1, Bing Huang2, Benjamin J Scherlag3, Jerry W Ritchey4, Abraham A Embi5, Jialu Hu6, Yuemei Hou7, Sunny S Po3.   

Abstract

BACKGROUND: Previous studies of the goat heart subjected to prolonged atrial pacing induced sustained atrial fibrillation (AF). Structural changes included marked accumulation of glycogen in atrial myocytes. AIMS: In the present study, we hypothesized that glycogen deposition in canine atrial myocytes promotes paroxysmal forms of AF and is involved in fibrosis development in the later stages of AF. MATERIAL &
METHODS: In dogs under pentobarbital anesthesia, tissues were obtained from the right and left atrial appendages (LAA/RAA). Periodic acid Schiff (PAS) and Masson's trichrome staining of the LAA/RAA from normal dogs, and those subjected to atrial pacing induced AF for 48 h or 8 weeks determined glycogen and collagen concentrations, respectively, using morphometric analysis.
RESULTS: At baseline, there was a significant greater concentration of glycogen in the LAA than the RAA (P ≤ 0.05). Compared to the RAA, the LAA glycogen, was dense and locked against the intercalated discs. After pacing induced AF for 48 hours and 8 weeks there was a marked increase in glycogen deposition, significantly greater than in the baseline state (P ≤ 0.05). There was a similar and progressive increase in collagen concentrations in each group (P ≤ 0.05).
CONCLUSIONS: The differential in glycogen concentration, in conjunction with other factors, neural and electrophysiological, provide a basis for the greater propensity of the left atrium for paroxysmal AF, at baseline and 48 hours of pacing induced AF. The marked increase in collagen at 8 weeks of pacing provides a substrate for sustained AF. Evidence is presented linking glycogen accumulation and fibrosis as factors in the persistent forms of AF.

Entities:  

Keywords:  Atrial fibrillation; fibrosis; glycogen

Mesh:

Substances:

Year:  2015        PMID: 25973058      PMCID: PMC4396299     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  23 in total

1.  Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle.

Authors:  M A Allessie; F I Bonke; F J Schopman
Journal:  Circ Res       Date:  1977-07       Impact factor: 17.367

2.  Vein of marshall cannulation for the analysis of electrical activity in patients with focal atrial fibrillation.

Authors:  C Hwang; T J Wu; R N Doshi; C T Peter; P S Chen
Journal:  Circulation       Date:  2000-04-04       Impact factor: 29.690

3.  Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation.

Authors:  Eugene Patterson; Sunny S Po; Benjamin J Scherlag; Ralph Lazzara
Journal:  Heart Rhythm       Date:  2005-06       Impact factor: 6.343

4.  Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat.

Authors:  J Ausma; N Litjens; M H Lenders; H Duimel; F Mast; L Wouters; F Ramaekers; M Allessie; M Borgers
Journal:  J Mol Cell Cardiol       Date:  2001-12       Impact factor: 5.000

5.  Disparate evolution of right and left atrial rate during ablation of long-lasting persistent atrial fibrillation.

Authors:  Mélèze Hocini; Isabelle Nault; Matthew Wright; George Veenhuyzen; Sanjiv M Narayan; Pierre Jaïs; Kang-Teng Lim; Sébastien Knecht; Seiichiro Matsuo; Andrei Forclaz; Shinsuke Miyazaki; Amir Jadidi; Mark D O'Neill; Frédéric Sacher; Jacques Clémenty; Michel Haïssaguerre
Journal:  J Am Coll Cardiol       Date:  2010-03-09       Impact factor: 24.094

6.  A focal source of atrial fibrillation treated by discrete radiofrequency ablation.

Authors:  P Jaïs; M Haïssaguerre; D C Shah; S Chouairi; L Gencel; M Hocini; J Clémenty
Journal:  Circulation       Date:  1997-02-04       Impact factor: 29.690

7.  The clinical significance of the atrial subendocardial smooth muscle layer and cardiac myofibroblasts in human atrial tissue with valvular atrial fibrillation.

Authors:  Jae Hyung Park; Hui-Nam Pak; Sak Lee; Han Ki Park; Jeong-Wook Seo; Byung-Chul Chang
Journal:  Cardiovasc Pathol       Date:  2012-05-31       Impact factor: 2.185

8.  Arrhythmogenic difference between the left and right atria during rapid atrial activation in a canine model of atrial fibrillation.

Authors:  Shinichi Niwano; Jisho Kojima; Hidehira Fukaya; Daisuke Sato; Masahiko Moriguchi; Hiroe Niwano; Yoshihiko Masaki; Tohru Izumi
Journal:  Circ J       Date:  2007-10       Impact factor: 2.993

9.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.

Authors:  M C Wijffels; C J Kirchhof; R Dorland; M A Allessie
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

10.  Glycogen and the propensity for atrial fibrillation: intrinsic anatomic differences in glycogen in the left and right atria in the goat heart.

Authors:  Abraham A Embi; Benjamin J Scherlag; Jerry W Ritchey
Journal:  N Am J Med Sci       Date:  2014-10
View more
  10 in total

1.  Metabolic activity of the left and right atria are differentially altered in patients with atrial fibrillation and LV dysfunction.

Authors:  Robert A deKemp; Rob S B Beanlands; Nicolas D Santi; Kai Yi Wu; C J Redpath; Pablo B Nery; Wayne Huang; Ian G Burwash; Jordan Bernick; George A Wells; Brian McArdle; Benjamin W J Chow; David H Birnie; Linda Garrard
Journal:  J Nucl Cardiol       Date:  2022-01-06       Impact factor: 3.872

2.  Prediction of Successful Pharmacological Cardioversion in Acute Symptomatic Atrial Fibrillation: The Successful Intravenous Cardioversion for Atrial Fibrillation (SIC-AF) Score.

Authors:  Jan Daniel Niederdöckl; Alexander Simon; Nina Buchtele; Nikola Schütz; Filippo Cacioppo; Julia Oppenauer; Sophie Gupta; Martin Lutnik; Sebastian Schnaubelt; Alexander Spiel; Dominik Roth; Fritz Wimbauer; Isabel Fegers-Wustrow; Katrin Esefeld; Martin Halle; Jürgen Scharhag; Thomas Laschitz; Harald Herkner; Hans Domanovits; Michael Schwameis
Journal:  J Pers Med       Date:  2022-03-30

3.  Growth differentiation factor-15 (GDF-15), novel biomarker for assessing atrial fibrosis in patients with atrial fibrillation and rheumatic heart disease.

Authors:  Yong-Ming Zhou; Ming-Jiang Li; Yan-Li Zhou; Le-Le Ma; Xin Yi
Journal:  Int J Clin Exp Med       Date:  2015-11-15

4.  Fibroblast growth factor-21 is positively associated with atrial fibrosis in atrial fibrillation patients with rheumatic heart disease.

Authors:  Rui Wang; Xin Yi; Xiaoyan Li; Xuejun Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

5.  Histopathological substrate of the atrial myocardium in the progression of obstructive sleep apnoea-related atrial fibrillation.

Authors:  Ling Zhang; Kun Ye; Jiasuoer Xiaokereti; Mei Ma; Yankai Guo; Xianhui Zhou; Baopeng Tang
Journal:  Sleep Breath       Date:  2021-01-07       Impact factor: 2.816

6.  The progression in atrial fibrillation patients with COPD: a systematic review and meta-analysis.

Authors:  Xiaoying Chen; Meiling Lin; Wei Wang
Journal:  Oncotarget       Date:  2017-10-26

7.  Metoprolol prevents chronic obstructive sleep apnea-induced atrial fibrillation by inhibiting structural, sympathetic nervous and metabolic remodeling of the atria.

Authors:  Li Sun; Sen Yan; Xiaoyu Wang; Shiqi Zhao; Hui Li; Yike Wang; Shuang Lu; Xinwen Dong; Jing Zhao; Shengzhu Yu; Minghui Li; Yue Li
Journal:  Sci Rep       Date:  2017-11-02       Impact factor: 4.379

8.  Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats.

Authors:  Wenjuan Liu; Wei Gong; Min He; Yemei Liu; Yeping Yang; Meng Wang; Meng Wu; Shizhe Guo; Yifei Yu; Xuanchun Wang; Fei Sun; Yiming Li; Linuo Zhou; Shengmei Qin; Zhaoyun Zhang
Journal:  J Diabetes Res       Date:  2018-10-14       Impact factor: 4.011

9.  Enhancing Fatty Acids Oxidation via L-Carnitine Attenuates Obesity-Related Atrial Fibrillation and Structural Remodeling by Activating AMPK Signaling and Alleviating Cardiac Lipotoxicity.

Authors:  Yudi Zhang; Yuping Fu; Tiannan Jiang; Binghua Liu; Hongke Sun; Ying Zhang; Boyuan Fan; Xiaoli Li; Xinghua Qin; Qiangsun Zheng
Journal:  Front Pharmacol       Date:  2021-11-26       Impact factor: 5.810

10.  Snail1 is positively correlated with atrial fibrosis in patients with atrial fibrillation and rheumatic heart disease.

Authors:  Furong Guo; Xin Yi; Mingjiang Li; Jinrong Fu; Sha Li
Journal:  Exp Ther Med       Date:  2017-08-31       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.